P
43.92
-1.06 (-2.35%)
| 前收盘价格 | 44.97 |
| 成交量 | 75,933 |
| 预期市盈率 (P/E Forward) | 9.82 |
| 价格/销量 (P/S) | 1.84 |
| 股市价格/股市净资产 (P/B) | 1.10 |
| 52周波幅 |
| 营业毛利率 | 18.86% |
| 营业利益率 (TTM) | 34.03% |
| 稀释每股收益 (EPS TTM) | 4.29 |
| 季度收入增长率 (YOY) | 7.10% |
| 季度盈利增长率 (YOY) | 1.40% |
| 总债务/股东权益 (D/E MRQ) | 56.91% |
| 流动比率 (MRQ) | 4.20 |
| 营业现金流 (OCF TTM) | 251.52 M |
| 杠杆自由现金流 (LFCF TTM) | 188.69 M |
| 资产报酬率 (ROA TTM) | 6.50% |
| 股东权益报酬率 (ROE TTM) | 12.30% |
AIStockmoo 评分
| 价值 38% | -1.8 |
| AI Insight 参考 | NA |
| 相对估值 参考 | -5.0 |
| 财务健康 参考 | 3.0 |
| 时机 38% | -1.1 |
| AI Technical 参考 | NA |
| 技术振荡指标 参考 | -2.5 |
| 技术平均移动指标 参考 | 1.0 |
| 市场情绪 25% | 0.0 |
| 分析师共识 参考 | 0.0 |
| 新闻情绪 参考 | NA |
| 聪明钱 | NA |
| 内部交易活动 参考 | NA |
| 机构资金流 参考 | NA |
| 市场环境 | ×1.15 |
| 宏观环境 参考 | -3.3 |
| 行业对比大市 (6个月) | -4.0% |
| 支柱一致性 | ×1.25 |
| 不计入评分 | |
| 价格波动 参考 | 1.8 |
| 最终评分 | -1.57 |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Prestige Consumer Healthcare In | 混合的 | 看跌 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| PBH | - | - | - | 1.10 |
| BHC | - | - | - | - |
| PRGO | - | 5.36% | - | 0.900 |
| EBS | - | - | - | 0.970 |
| RDY | - | 0.68% | - | 3.07 |
| TAK | - | 4.61% | - | 1.43 |
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 1.23% |
| 机构持股比例 | 108.15% |
该时间范围内无数据。
该时间范围内无数据。
投资组合